scholarly journals Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy

2018 ◽  
Vol 24 (4) ◽  
pp. 427-437 ◽  
Author(s):  
Nisha M Badders ◽  
Ane Korff ◽  
Helen C Miranda ◽  
Pradeep K Vuppala ◽  
Rebecca B Smith ◽  
...  
2001 ◽  
Vol 29 (2) ◽  
pp. 222-227 ◽  
Author(s):  
I. J. McEwan

The androgen receptor is a member of the nuclear receptor superfamily, and regulates gene expression in response to the steroid hormones testosterone and dihydrotestosterone. Mutations in the receptor have been correlated with a diverse range of clinical conditions, including androgen insensitivity, prostate cancer and spinal bulbar muscular atrophy, a neuromuscular degenerative condition. The latter is caused by expansion of a polyglutamine repeat within the N-terminal domain of the receptor. Thus the androgen receptor is one of a growing number of neurodegenerative disease-associated proteins, including huntingtin (Huntington's disease), ataxin-1 (spinocerebellar ataxia, type 1) and ataxin-3 (spinocerebellar ataxia, type 3), which show expansion of CAG triplet repeats. Although widely studied, the functions of huntingtin, ataxin-1 and ataxin-3 remain unknown. The androgen receptor, which has a well-recognized function in gene regulation, provides a unique opportunity to investigate the functional significance of poly(amino acid) repeats in normal and disease states.


2006 ◽  
Vol 34 (6) ◽  
pp. 1098-1102 ◽  
Author(s):  
J. Duff ◽  
P. Davies ◽  
K. Watt ◽  
I.J. McEwan

The AR (androgen receptor) is a ligand-activated transcription factor that mediates the action of the steroids testosterone and dihydrotestosterone. Alterations in the AR gene result in a number of clinical disorders, including: androgen-insensitivity, which leads to disruption of male development; prostate cancer; and a neuromuscular degenerative condition termed spinal bulbar muscular atrophy or Kennedy's disease. The AR gene is X-linked and the protein is coded for by eight exons, giving rise to a C-terminal LBD (ligand-binding domain; exons 4–8), linked by a hinge region (exon 4) to a Zn-finger DBD (DNA-binding domain; exons 2 and 3) and a large structurally distinct NTD (N-terminal domain; exon 1). Identification and characterization of mutations found in prostate cancer and Kennedy's disease patients have revealed the importance of structural dynamics in the mechanisms of action of receptors. Recent results from our laboratory studying genetic changes in the LBD and the structurally flexible NTD will be discussed.


2013 ◽  
Vol 34 (5) ◽  
pp. 1516.e17-1516.e19 ◽  
Author(s):  
Pietro Fratta ◽  
Bilal Malik ◽  
Anna Gray ◽  
Albert R. La Spada ◽  
Michael G. Hanna ◽  
...  

2008 ◽  
Vol 53 (5) ◽  
pp. 729-740 ◽  
Author(s):  
Douglas Ashley Monks ◽  
Pengcheng Rao ◽  
Kaiguo Mo ◽  
Jamie Ann Johansen ◽  
Gareth Lewis ◽  
...  

1996 ◽  
Vol 142 (1-2) ◽  
pp. 12-16 ◽  
Author(s):  
Hideto Nakajima ◽  
Fumiharu Kimura ◽  
Toshimasa Nakagawa ◽  
Daisuke Furutama ◽  
Keiichi Shinoda ◽  
...  

Neuron ◽  
2014 ◽  
Vol 82 (2) ◽  
pp. 295-307 ◽  
Author(s):  
Constanza J. Cortes ◽  
Shuo-Chien Ling ◽  
Ling T. Guo ◽  
Gene Hung ◽  
Taiji Tsunemi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document